A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.
(Q50561584)
scientific article published in February 1998
scientific article published in February 1998
Language:
other details
description | scientific article published in February 1998 |
External Links
(P356) |
10.1016/S0167-8140(97)00220-X
|
(P698) |
9510041
|